Herpes simplex virus 1 encodes at least four genes whose functions include blocking apoptosis induced by exogenous agents (e.g., sorbitol, Fas ligand, and BAD protein) or replication-incompetent mutants (e.g., the d120 mutant lacking both copies of the ␣4 gene). U S3, one of these four genes, encodes a serine-threonine kinase that has been demonstrated to block apoptosis induced by proapoptotic cellular proteins or by the d120 mutant. The amino acid context of serine-threonine phosphorylated by U S3 is similar to that of the cAMP-dependent protein kinase PKA. We report that (i) the pattern of proteins phosphorylated by U S3 in transduced cells or in cells infected with WT virus overlaps that of phosphoproteins targeted by PKA, (ii) activation of PKA blocks apoptosis induced by d120 mutant or by BAD protein independently of U S3, (iii) US3 protein kinase phosphorylates peptides containing the serine or threonine targeted by PKA including that present in the regulatory type II␣ subunit of PKA, and (iv) in WT virus-infected cells the regulatory type II␣ subunit is phosphorylated in a US3-dependent manner. We conclude that a major determinant of the antiapoptotic activity of the U S3 protein kinase is the phosphorylation of PKA substrates by either or both enzymes.
H
erpes simplex virus 1 (HSV-1) blocks apoptosis induced by exogenous agents such as FAS ligand (1) (2) (3) (4) , sorbitol (1, (5) (6) (7) , and activated proapoptotic cellular proteins (8) (9) (10) (11) (12) , or by replication-incompetent mutants such as those lacking the viral regulatory genes encoding ICP4 (1, (13) (14) (15) or ICP27 (16) . Our laboratory reported that viral glycoprotein D, glycoprotein J, and the protein kinase encoded by the U S 3 gene each blocks apoptosis induced by replication-incompetent mutants or by proapoptotic cellular proteins such as BAD (1, 5, 8, 9, 14, 15, 17) . Other studies added viral ribonucleotide reductase to the list of antiapoptotic viral proteins (18) . These studies were confirmed and extended in numerous subsequent studies (2, 3, 7, (10) (11) (12) . Inasmuch as U S 3 protein kinase can block apoptosis induced by proapoptotic cellular proteins or replication-incompetent d120 mutant, which lacks both copies of the ␣4 gene in the absence of other viral proteins, it could be predicted that U S 3 protein exerts its function through phosphorylation of specific cellular substrates. The identity of these substrate(s) has so far remained elusive. In vitro studies on synthetic peptides have characterized a U S 3 optimal consensus sequence as (R) n X(S͞T)YY, where n ϭ 3, X can be Arg, Ala, Val, Pro, or Ser, and Y can be any of these residues except that an acidic residue is unacceptable in those positions (19) . This sequence closely resembles the target sequence of the cellular cAMP-dependent protein kinase PKA (20) . Interestingly, extensive literature indicates that PKA is a key enzyme important in the regulation of metabolism, survival, and proliferation of eukaryotic cells, and it mediates most of the biological effects of the second messenger cAMP (20) (21) (22) (23) (24) (25) . Structurally, the enzyme is an inactive tetramer composed of two regulatory (R) and two catalytic subunits. Each R subunit binds two molecules of cAMP, causing the holoenzyme to dissociate and the catalytic subunits to be released and become available to phosphorylate target proteins. Four types of R subunits have been identified, I␣, I␤, II␣, and II␤. They differ in molecular mass, physiochemical properties, and tissue distribution. One important difference is that RII but not RI subunits can be phosphorylated by the catalytic subunits, and this event enhances net dissociation and activation of the catalytic subunits (25, 26) . Further regulation of the PKA pathway is provided by anchoring proteins (AKAPs) that sequester PKA to a specific subcellular location by binding to the R subunits (25) .
In this article we report that the U S 3 protein kinase may work by activating PKA and by phosphorylating proteins targeted by activated PKA.
Materials and Methods
Cells and Viruses. SK-N-SH and HEp-2 cell lines obtained from the American Type Culture Collection were grown in DMEM containing 5% (HEp-2) or 10% (SK-N-SH) newborn calf serum. Rabbit skin cells were originally obtained by J. McLaren and grown in DMEM supplemented with 5% newborn calf serum. Insect cell line Sf9 (Spodoptera frugiperda) was obtained from Pharmingen. HSV-1(F) is the prototype HSV-1 strain used in the laboratory. The HSV-1(KOS) d120 mutant, a kind gift from N. DeLuca (University of Pittsburgh, Pittsburgh), lacks both copies of the ␣4 gene and was grown in a Vero-derived cell line (E5) expressing the ␣4 gene (13) . The recombinant virus R7041, lacking the U S 3 gene, is described in ref. 27 .
Antibodies. Rabbit polyclonal antibody against phosphorylated (Ser͞Thr) PKA substrates (Cell Signaling Technology, Beverly, MA) was used at a dilution of 1:1,000. Rabbit polyclonal antibodies against PKA RII␣ subunit and poly(ADP-ribosyl) synthetase (PARP) (Santa Cruz Biotechnology) were used at a dilution of 1:200 and 1:700, respectively. The polyclonal antibody to ICP22 is described in ref. 28 . Monoclonal antibodies to ICP0 and ICP27 were purchased from the Goodwin Institute (Plantation, FL).
Baculoviruses. Construction of transfer plasmids encoding U S 3 and gstBAD3S͞A proteins under the control of the immediateearly cytomegalovirus promoter is described in refs. 11 and 16. The baculoviruses expressing U S 3 or gstBAD3S͞A were constructed by cotransfecting the respective transfer plasmids with BaculoGold DNA (Pharmingen).
Purification of GST-US3 Protein. The U S 3 coding sequence was transferred from U S 3-MTS-1 into a suitable transfer plasmid. GST-U S 3-and GST-expressing baculoviruses were constructed by cotransfecting the respective transfer plasmids with BaculoGold DNA. Infected Sf9 cultures were harvested, rinsed twice with PBS (0.14 M NaCl͞3 mM KCl͞10 mM Na 2 HPO 4 ͞1.5 mM KH 2 PO 4 ) and lysed in radioimmunoprecipitation assay buffer (1% Nonidet P-40͞0.5% sodium deoxycholate͞0.1% SDS in PBS) in the presence of protease inhibitors (Complete, Roche) as recommended by the manufacturer. Lysed cells were held on ice for 10 min before brief sonication and centrifugation at 14,000 rpm for 10 min in an Eppendorf 5415 C centrifuge. The GST-chimeric proteins were bound to glutathione Sepharose beads (Amersham Biosciences), rinsed four times with PBS, and stored at 4°C.
Immunoblot Assays. Cells grown in 25-cm 2 flasks were either mock-infected or exposed to 10 pfu of virus per cell for 1 h and 30 min at 37°C in medium 199V [mixture 199 (Sigma) supplemented with 1% calf serum] and then maintained in DMEM supplemented with the proper amount of serum. Cells were harvested at the indicated times after infection, rinsed three times with PBS, and solubilized in radioimmunoprecipitation assay buffer in the presence of phosphatase inhibitors (10 mM NaF͞10 mM ␤-glycerophosphate͞0.1 mM sodium vanadate) and protease inhibitors (Complete). Lysed cells were stored on ice for 10 min before centrifugation at 14,000 rpm for 10 min. The protein concentration of the supernatant fluids was determined with the aid of a Bio-Rad protein assay. Protein samples denatured in disruption buffer (50 mM Tris, pH 7.0͞2.75% sucrose͞5% 2-mercaptoethanol͞2% SDS) were heated at 95°C for 5 min, electrophoretically separated in denaturing polyacrylamide gels, electrically transferred to a nitrocellulose sheet, blocked, and reacted with primary antibody followed by appropriate secondary antibody conjugated to alkaline phosphatase (Bio-Rad). Protein bands were visualized with 5-bromo-4-chloro-3-indolylphosphate͞nitroblue tetrazolium (Denville Scientific, Metuchen, NJ).
DEVDase Activity Assay. Caspase 3 activity was assayed by using a tetrapeptide conjugated to phenylnitraniline (DEVD-pNA) (Biomol) (5, 8, 9, 15) . Cells were harvested at the indicated times after infection with 10 pfu of virus per cell, rinsed three times with PBS, resuspended in 75 l of lysis solution A {0.1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate͞50 mM Hepes, pH 7.4͞1 mM DTT͞0.1 mM EDTA}, held on ice for 10 min, and centrifuged at 14,000 rpm for 10 min at 4°C. Equal amounts of protein in supernatant fluids were tested for DEVDase activity according to the manufacturer's instructions (Biomol).
Kinase Assays. One microgram of GST or GST-U S 3 attached to glutathione Sepharose beads was reacted with either 2 or 4 g of the indicated substrates, in 50 l of kinase buffer (20 mM Tris⅐HCl, pH 7.5͞50 mM KCl͞10 mM MgCl 2 ͞10 mM 2-mercaptoethanol), supplemented with 100 M ATP and 20 Ci (1 Ci ϭ 37 GBq) of [␥-32 P]ATP. The samples were reacted at 30°C for 30 min. The beads were pelleted by low-speed centrifugation, and 35 l of the supernatant was spotted onto cellulose phosphate paper filters (Whatman P81). The filters were rinsed four times with 0.5% H 3 PO 4 for 5 min each time and rinsed with ethanol, and the amount of bound radioactivity was measured with a Beckman LS 8000 scintillation counter. Alternatively, 4 g of histone H1 was reacted with the kinase as described above. The reactions were terminated by the addition of gel-loading buffer, heated to 95°C for 5 min, resolved by PAGE, transferred to nitrocellulose membrane, and analyzed by autoradiography. Quantification of 32 P phosphorylation of the substrates was done with the aid of a Molecular Dynamics Storm 860 PhosphorImager.
Results

The Profile of Phosphorylated Serines and Threonines in the Context of the Sequence Arg-X-X-Thr*-X-X or Arg-Arg-X-Ser*-X-X in Cells Transduced with the U S3 Protein Kinase Is Similar to That of Cells
Infected with WT HSV-1. At 18 h after mock infection or transduction with WT baculovirus (Bac-WT), a baculovirus expressing the U S 3 protein kinase (Bac-U S 3), or infection with WT HSV-1(F), or with mutants lacking the U S 3 ORF (R7041) or the ␣4 genes (d120), SK-N-SH cells were harvested, solubilized, and subjected to electrophoresis on denaturing gels. The electrophoretically separated proteins reacted with an antibody specific for phosphorylated serines and threonines in the context of the sequences Arg-X-X-Thr*-X-X or Arg-Arg-X-Ser*-X-X. This antibody is used to identify the proteins phosphorylated by PKA. As shown in Fig. 1 , the antibody reacted with a small number of bands in lysates of cells that were either mock-infected or transduced with Bac-WT or infected with R7041(⌬U S 3) or d120 (⌬␣4) mutants (lanes 1, 2, 5, and 6). In contrast, the antibody reacted with a large number of bands in lysates of cells infected with HSV-1(F) or exposed to a Bac-U S 3 (lanes 3 and 4). Of particular interest are the patterns of phosphoproteins detected in cells doubly infected with d120 mutant and a baculovirus expressing the U S 3 protein kinase (lanes 6-8). Many of the numerous phosphoprotein bands reactive with the antibody appeared to comigrate with phosphoprotein bands in cells infected with a Bac-U S 3 or HSV-1(F). Comparable results were obtained after ectopic expression of U S 3 in HEp-2 cells or in rabbit skin cells (data not shown). We conclude from these studies that U S 3 protein kinase mediates the phosphorylation of PKA target sequences Arg-X-X-Thr-X-X or Arg-Arg-XSer-X-X.
Forskolin Blocks Apoptosis Induced by Infection of Cells with d120
Mutant or Transduction with BAD. The results shown in Fig. 1 suggest that either the U S 3 protein kinase has a substrate similar to that of PKA or the U S 3 protein kinase activates PKA, and this, in turn, activates an antiapoptotic pathway. Two series of experiments were done to test the hypothesis that activated PKA can block apoptosis induced by the d120 mutant or BAD. In the first, replicate cultures of HEp-2 cells infected with d120 mutant were exposed to an increased amount of forskolin, a PKA activator. As shown in Fig. 2A , caspase 3 activity induced by the d120 infection decreased as a function of forskolin concentration in the medium. Light microscopic examination revealed complete destruction of the cells in untreated cultures or cultures exposed to low doses of forskolin and a virtually intact cell monolayer in infected cells treated with the highest dose of forskolin. Forskolin (100 M) also blocked the activation of caspase 3 in rabbit skin cells transduced with a form of GST-BAD in which all of the serines subject to inhibitory phosphorylation had been replaced with alanines as reported in ref. 9 and as shown in Fig. 2C . Finally, forskolin blocked activation of caspase 3 in SK-N-SH cells exposed to the d120 mutant (Fig. 2B) .
In the second series of experiments replicate cultures of mock-infected or d120-mutant-infected cells were exposed to forskolin (100 M). At 18 h after infection the cells were harvested, processed as described in the legend to Fig. 3 , and reacted with antibody to PARP. The results (Fig. 3A, lanes 1-4) showed that forskolin blocked the caspase 3-dependent cleavage of PARP that is characteristic of d120-mutant-infected cells (lane 3) (5). To determine whether forskolin blocks the expression of viral genes in d120-mutant-infected cells, aliquots of the lysates probed for the status of PARP were probed with antibodies to ␣ proteins known to be produced in cells infected with this mutant. As shown in Fig. 3 B-D , the accumulation of the ␣ proteins ICP0, ICP22, or ICP27 in forskolin-treated cells (lane 4) could not be differentiated from those present in untreated cells (lane 3). Hence, forskolin did not act by blocking the expression of replication-defective mutant. Other studies have shown that foskolin did not enable the d120 mutant to express the U S 3 gene (data not shown).
We conclude from this series of experiments that forskolin blocks apoptosis induced either by d120 mutant or BAD in a manner analogous to that of U S 3 protein kinase.
Forskolin Acts by Activating PKA. As noted in the Introduction, PKA is activated by cAMP or phosphorylation of the regulatory Cells were harvested 18 h after infection, and the cell lysates were assayed for DEVDase activity. (B) SK-N-SH cells were either mock-infected or infected with d120 mutant (10 pfu per cell) in the presence of 100 M forskolin. Cells were harvested 18 h after the infection and assayed for DEVDase activity. (C) Rabbit skin cells were either mock-infected or transduced with a baculovirus expressing gstBAD3S͞A (10 pfu per cell), in the presence or absence of 100 M forskolin. Cells were harvested 18 h after infection and assayed for DEVDase activity. In lanes 4 and 5, cells were exposed to either Bac-WT or Bac-U S3 for 6 h, superinfected with Bac-gstBAD3S͞A for 18 h, lysed, and assayed for DEVDase activity. type II subunits and is blocked by the interaction of the catalytic subunit with an inhibitory peptide (p-PKI) (29) . Forskolin has been shown to activate PKA by increasing the levels of cAMP in infected cells. To test whether the antiapoptotic activity of forskolin is exerted by activation of PKA, we exposed cells infected with d120 mutant to forskolin and the p-PKI peptide. The expectation was that if forskolin acts by activating PKA, p-PKI would inhibit PKA and block the antiapoptotic activity exerted by forskolin. If forskolin acts by another mechanism, p-PKI would not block the antiapoptotic effect. We report two series of experiments. In the first, replicate cultures of HEp2 cells were exposed to p-PKI (100 M), d120 mutant (10 pfu per cell), d120 mutant and forskolin (100 M), or d120 mutant, p-PKI, and forskolin. As shown in Fig. 4A , forskolin decreased the level of caspase 3 induced by the d120 mutant. This decrease was reversed in cells exposed to p-PKI.
The results of the second series of experiments are illustrated in Fig. 4B . In these experiments cells exposed to d120 mutant (10 pfu per cell) alone or in combination with forskolin (50 M) were exposed to increasing amounts of p-PKI. The cells were harvested 18 h after infection and tested for caspase activity as described in Materials and Methods. The results show that forskolin decreased the activation of caspase 3 activity characteristic of d120-mutant-infected cells and that p-PKI caused a dose-dependent increase in caspase 3 activity.
We conclude from this series of experiments that forskolin blocks the proapoptotic functions induced by the d120 mutant by activating PKA.
US3 Protein Kinase Phosphorylates PKA Substrates. The objective of this series of experiments was to determine whether U S 3 protein kinase phosphorylates PKA substrates. Purified GST-U S 3 chimeric protein was reacted with a panel of PKA substrate peptides and proteins. The procedures for the purification of GST-U S 3 protein and for measuring the phosphorylation of the substrates are described in Materials and Methods. We used GST-U S 3 because it is readily purified and is active in phosphorylating known substrates. The results of three separate experiments are shown in Fig. 5 A-C . The results presented here show that GST-U S 3 phosphorylates in vitro both peptides known to be substrates of PKA (CREB-tide, KEMP-tide, RII␣ residues 81-99) and intact proteins (e.g., histone H1) known to be targets of PKA phosphorylation (20) . A peptide containing the target site of phosphorylation by casein kinase II served as a negative control and was not phosphorylated by GST-U S 3.
The US3 Protein Kinase Mediates the Posttranslational Modification of
the RII␣ Catalytic Subunit of PKA in WT HSV-1-Infected Cells. The experiments described above indicated that peptides derived from RII␣ catalytic subunit of PKA were phosphorylated in vitro by the U S 3 protein kinase. The experiments described here were conducted to determine whether the RII␣ subunit of PKA was posttranslationally modified in a U S 3-kinase-dependent manner. HEp-2 cells were mock-infected or infected with HSV-1(F), or the mutant viruses R7041 and d120. At different times after infection, the cells were harvested, lysed, and immunoblotted for the RII␣ subunit. As shown in Fig. 6 , an additional band appears 6 h after infection with HSV-1 but not after infection with the mutants that do not express U S 3. A similar modification was observed in a similar experiment done in SK-N-SH cells. As predicted, forskolin treatment of either cell line did not cause the posttranslational modification seen in WT-virus-infected cells. Additionally, the RII␤ subunit was not detected in HEp-2 cells. Whereas the RII␤ subunit was detected in SK-N-SH cells, it was not posttranslationally modified after ectopic expression of the U S 3 protein kinase (data not shown). These results are consistent with the phosphorylation of the RII␣ peptide reported in the preceding section and indicate that RII␣ is also modified in a U S 3-dependent fashion in infected cells.
Discussion
An impressive feature of WT HSV-1-infected cells is that the virus blocks apoptosis induced by a variety of exogenous agents (1-6). Moreover, whereas cells infected by WT virus do not undergo apoptosis, at least three replication-incompetent deletion mutants, that is, mutants lacking the essential genes ␣4 (13-15), ␣27 (16), or glycoprotein D (17), induce apoptosis. The apoptosis induced by mutants lacking glycoprotein D is blocked by ectopic expression of glycoproteins D or J (17), whereas that induced by ⌬␣4 mutant is alleviated by the ectopic expression of the U S 3 protein kinase (14, 15) . The viral protein kinase also blocks the proapoptotic activity of ectopically expressed BAD protein and that of other proapoptotic proteins (8) (9) (10) (11) (12) . Although it has been assumed that U S 3 protein kinase acts by phosphorylating specific target proteins, the targets themselves remained elusive. In light of the many apparent proapoptotic proteins whose function is blocked by the U S 3 protein, we sought to determine whether U S 3 could have a cellular counterpart that could be involved in blocking proapoptotic events, which could interfere with viral replication. The context of the serines or threonines phosphorylated by U S 3 protein kinase pointed to the cAMP-dependent protein kinase PKA (20, 25) . In this study we report several findings that alter the fundamental perception of the function of the U S 3 protein kinase. Specifically we show the following.
(i) The fundamental hypothesis of these studies is that U S 3 activates PKA by phosphorylating one of its regulatory subunits, and that apoptosis is blocked by the concerted action of both activated PKA and U S 3 protein kinase. To activate PKA we used forskolin, a drug commonly used for this purpose. The evidence that forskolin acted by activating PKA is based on the observation that p-PKI, a specific inhibitor of the catalytic subunit, reversed the effect of forskolin.
(ii) Activation of PKA blocked apoptosis induced by the replication defective ⌬␣4 mutant d120 in the absence of ectopic expression of the U S 3 protein kinase. This mutant induces classical apoptosis in a wide variety of cell lines (1, 5) , and earlier studies have shown that apoptosis induced by the d120 mutant is blocked by ectopic expression of the U S 3 protein kinase (14, 15) . In infected cells, the d120 mutant expresses only the ␣ or immediate early genes, and most likely it is the expression of these genes that induces apoptosis. As shown in Fig. 3 , forskolin did not block apoptosis by blocking the synthesis of ␣ proteins.
(iii) In earlier studies we used an ectopically expressed BAD protein as a model for the study of apoptosis by activation of a proapoptotic protein. In these studies, the U S 3 protein kinase blocked apoptosis induced by BAD (8, 9) . To enhance its activity, the coding sequence of BAD protein was modified by substitution of three serines, which, when phosphorylated, preclude the protein from inducing apoptosis (9) . Activation of PKA also blocked apoptosis induced by the modified BAD3S͞A protein in the absence of U S 3 protein kinase.
Relevant to the results and conclusions of these studies are the following.
(i) Extensive literature indicates that PKA plays an important role in regulating apoptosis in eukaryotic cells (21) (22) (23) (24) . The data presented in this report indicates that in the experimental context used in these studies, activated PKA performed the same functions as the U S 3 protein kinase in blocking apoptosis induced by either a replication deficient virus or a proapoptotic cellular protein.
(ii) The model we propose is that the substrate specificity of the U S 3 protein kinase is similar to that of PKA, that PKA can be activated, and that either U S 3 alone or both enzymes phosphorylate specific PKA substrates to block apoptosis (Fig. 7) . In the few examples presented in this report, we showed that U S 3 phosphorylated several peptides known to contain PKA phos- of the indicated peptides were reacted with 1 g of purified GST or GST-Us3 attached to glutathione Sepharose beads, as described in the text. Phosphorylated substrates were adsorbed onto cellulose phosphate paper filters, and radioactivity was measured with a scintillation counter. The data show the increase in cpm over a mock reaction carried out with no substrate. (C) Four micrograms of histone H1 were reacted with 1 g of purified GST or GST-US3 attached to glutathione Sepharose beads, as described in the text. Samples were subjected to polyacrylamide gel electrophoresis, nitrocellulose membrane transfer, and autoradiography. phorylation sites. One of these peptides contained the autophosphorylation site for the RII␣ subunit of PKA. In another experiment we showed that PKA RII␣ was phosphorylated in infected cells in a U S 3-protein-kinase-dependent manner. At this time it is not clear whether the actual block of apoptosis is due to activation of PKA or the function of both PKA and U S 3 enzymes. Inasmuch as U S 3 mediated the posttranslational modification of the RII␣ but not the RII␤ subunit, the question arises whether tetramers containing both RII␣ and RII␤ can be activated by U S 3 protein kinase.
(iii) A well documented antiapoptotic function of activated PKA is the phosphorylation of one of the regulatory residues of BAD, Ser-155 (20, 21) . This phosphorylation prevents the binding of BAD to antiapoptotic members of the Bcl-2 family and therefore results in inactivation of BAD itself. However, in the studies reported here, activation of PKA by forskolin was sufficient to block apoptosis induced by a mutant of BAD in which the regulatory phosphorylation sites were mutated. This result is of particular interest because it suggests that the activation of PKA can produce a redundancy of antiapoptotic events. Such a redundancy may explain why U S 3 has been implicated in protection against apoptosis induced by many and different unrelated stimuli (3, 7-12, 14, 15) . Simultaneous activation of several antiapoptotic pathways by a single viral protein would be highly beneficial to the virus.
Lastly, it is of interest to note that activation of PKA by the U S 3 protein kinase conforms with and extends our understanding of the fundamental strategy by which HSV-1 takes control of the infected cell. Earlier studies have shown that HSV scavenges the cell for useful proteins and diverts them to serve the needs of the virus (30) (31) (32) (33) . Although our data suggest that U S 3 protein kinase interacts with and activates PKA, the data also indicate that the enzyme mimics and usurps the functions of activated PKA. Fig. 7 . A model for the antiapoptotic interplay between US3 and PKA. Earlier studies have shown that the U S3 protein kinase blocks apoptosis induced by d120, a replication-incompetent virus, and by ectopically expressed BAD protein. This report shows that activated PKA blocks apoptosis induced by either d120 mutant or BAD protein, and that U S3 can phosphorylate PKA substrates including the autophosphorylation site of the RII␣ subunit of PKA. The model predicts that the U S3 protein kinase activates PKA, and that either PKA or both PKA and U S3 enzymes block apoptosis.
